✦ LIBER ✦

Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group

✍ Scribed by Giuseppe Frasci; Giuseppe D'Aiuto; Pasquale Comella; Anna Apicella; Renato Thomas; Immacolata Capasso; Maurizio Di Bonito; Giacomo Cartenì; Maria Biglietto; Luigi De Lucia; Luigii Maiorino; Sergio Piccolo; Ugo Bianchi; Roberta D'Aniello; Liliana Lapenta; Giuseppe Comella

Book ID: 110233663
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 91 KB
Volume: 56
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1006263226099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin–epirubicin–paclitaxel weekly a

Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study

✍ Giuseppe Frasci; Giuseppe D'Aiuto; Pasquale Comella; Renato Thomas; Immacolata C 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 88 KB

Phase II study of bi-weekly administrati

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

✍ Polee, M B; Eskens, F A L M; van der Burg, M E L; Splinter, T A W; Siersema, P D 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB

Cisplatin, dacarbazine, and fotemustine

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma : A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

✍ Antonio Daponte; Paolo A. Ascierto; Adriano Gravina; Maria Teresa Melucci; Giuse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

Oxaliplatin, irinotecan, and fluorouraci

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

✍ Pasquale Comella; Vito Lorusso; Luigi Maiorino; Rossana Casaretti; Michele Canno 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 274 KB

Paclitaxel and carboplatin as first-line

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group

✍ George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Sk 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

High-dose epirubicin and r-met-hu G-CSF

High-dose epirubicin and r-met-hu G-CSF (Filgrastim) in the treatment of patients with advanced breast cancer: A hellenic cooperative oncology group study

✍ Fountzilas, George ;Skarlos, Demosthenis ;Katsohis, Constantine ;Pavlidis, Nicho 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB